VistaGen Therapeutics Inc. (NASDAQ: VTGN) Stock Information | RedChip

VistaGen Therapeutics Inc. (NASDAQ: VTGN)


$3.89
+0.0500 ( +1.30% ) 94.2K

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Market Data


Open


$3.89

Previous close


$3.84

Volume


94.2K

Market cap


$105.67M

Day range


$3.72 - $3.96

52 week range


$1.63 - $24.71

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 2 Mar 06, 2024
4 Insider transactions 2 Mar 06, 2024
4 Insider transactions 2 Mar 06, 2024
4 Insider transactions 2 Mar 06, 2024
4 Insider transactions 2 Mar 06, 2024
8-k 8K-related 17 Feb 13, 2024
10-q Quarterly Reports 50 Feb 13, 2024
8-k 8K-related 76 Jan 09, 2024
4 Insider transactions 2 Jan 03, 2024
8-k 8K-related 15 Jan 03, 2024

Latest News